| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |